Colorectal cancer in middle-aged women in relation to hormonal status: A report from the Women's Health in the Lund Area (WHILA) study

References

• Levin B. Neoplasm of the large and small intestine. Cecil text book of medicine. 21st ed, L Goldman, J C Benneth. Saunders, Philadelphia, PA 2000; 741–742
   Google Scholar
• Thörn M, Bergström R, Kressner U, Sparen P, Zack M, Ekbom A. Trends in colorectal cancer incidence in Sweden 1959–93 by gender, localization, time period, and birth cohort. Cancer Causes Control 1998; 9: 145–152
   Google Scholar
• Hakama M, Hoff G, Kronborg O, Pahlman L. Screening for colorectal cancer. Acta Oncol 2005; 44: 425–439
   PubMed Web of Science ®Google Scholar
• Birgisson H, Talback M, Gunnarsson U, Pahlman L, Glimelius B. Improved survival in cancer of colon and rectum in Sweden. Eur J Surg Oncol 2005; 31: 845–853
   PubMed Web of Science ®Google Scholar
• Anon. Colorectal cancer. The Merck manual of diagnosis and therapy. 17th ed, M Beers, R Berkow. Merck Research Laboratories, Rahway, NJ 1999; 328–330
   Google Scholar
• Slattery M L, Potter J D, Curtin K, Edwards S, Ma K N, Anderson K, Schaffer D, Samowitz W S. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res 2001; 61: 126–130
   PubMed Web of Science ®Google Scholar
• Frezza E E, Wachtel M S, Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer. Gut 2006; 55: 285–291
   PubMed Web of Science ®Google Scholar
• Hou L, Ji B T, Blair A, Dai Q, Gao Y T, Potter J D, Chow W H. Body mass index and colon cancer risk in Chinese people: menopause as an effect modifier. Eur J Cancer 2006; 42: 84–90
   PubMed Web of Science ®Google Scholar
• Gerhardsson M, Floderus B, Norell S E. Physical activity and colon cancer risk. Int J Epidemiol 1988; 17: 728–729
   Google Scholar
• Gerhardsson M, Steineck G, Norell S E. Colorectal cancer in Sweden. A descriptive epidemiologic study. Acta Oncol 1990; 29: 855–861
   PubMed Web of Science ®Google Scholar
• Park S K, Joo J S, Kim D H, Kim Y E, Kang D, Yoo K Y. Association of serum lipids and glucose with the risk of colorectal adenomatous polyp in men: a case–control study in Korea. J Korean Med Sci 2000; 15: 690–695
   PubMed Web of Science ®Google Scholar
• Suzuki K, Ito Y, Wakai K, Kawado M, Hashimoto S, Toyoshima H, Kojima M, Tokudome S, Hayakawa N, Watanabe Y, et al. Japan Collaborative Cohort Study Group. Serum oxidized low-density lipoprotein levels and risk of colorectal cancer: a case–control study nested in Japan Collaborative Cohort Study. Cancer Epidemiol Biomarkers Prev 2004; 13: 1781–1787
   PubMed Web of Science ®Google Scholar
• Shemerovskii K A. [Constipation – a risk factor for the colorectal cancer]. Klin Med (Mosk) 2005; 83: 60–64
   Google Scholar
• Chen K, Qui J L, Zhang Y, Zhao Y W. Meta analysis of risk factors for colorectal cancer. World J Gastroenterol 2003; 9: 1589–1600
   Google Scholar
• Terry P, Ekbom A, Lichtenstein P, Feychting M, Wolk A. Long-term tobacco smoking and colorectal cancer in a prospective cohort study. Int J Cancer 2001; 91: 585–587
   PubMed Web of Science ®Google Scholar
• Engeland A, Andersen A, Haldorsen T, Tretli S. Smoking habits and risk of cancers other than lung cancer: 28 years' follow-up of 26,000 Norwegian men and women. Cancer Causes Control 1996; 7: 497–506
   PubMed Web of Science ®Google Scholar
• Jassam N, Bell S M, Speirs V, Quirke P. Loss of expression of oestrogen receptor β in colon cancer and its association with Dukes' staging. Oncol Rep 2005; 14: 17–21
   PubMed Web of Science ®Google Scholar
• Korenaga D, Orita H, Maekawa S, Itasaka H, Ikeda T, Sugimachi K. Relationship between hormone receptor levels and cell-kinetics in human colorectal cancer. Hepatogastroenterology 1997; 44: 78–83
   Google Scholar
• Bassalyk L S, Korotkova T V, Prorokov V V, Murav'eva N I, Smirnova K D. [Prognostic value of the level of steroid hormone receptors in cancer of the large intestine]. Vopr Onkol 1987; 33: 43–46
   Google Scholar
• Burkman R T. Reproductive hormones and cancer: ovarian and colon cancer. Obstet Gynecol Clin North Am 2002; 29: 527–540
   PubMed Web of Science ®Google Scholar
• Kampman E, Potter J D, Slattery M L, Caan B J, Edwards S. Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case–control study in the United States. Cancer Causes Control 1997; 8: 146–158
   Google Scholar
• Grodstein F, Newcomb P A, Stampfer M J. Postmenopausal hormone therapy and the risk of colorectal cancer: a review of meta-analysis. Am J Med 1999; 106: 574–582
   PubMed Web of Science ®Google Scholar
• Rossouw J E, Anderson G L, Prentice R L, LaCroix A Z, Kooperberg C, Stefanick M L, Jackson R D, Beresford S A, Howard B V, Johnson K C, et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002; 288: 321–333
   PubMed Web of Science ®Google Scholar
• Anderson G L, Limacher M, Assaf A R, Bassford T, Beresford S A, Black H, Bonds D, Brunner R, Brzyski R, Caan B, et al. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2004; 291: 1701–1712
   PubMed Web of Science ®Google Scholar
• Lidfeldt J, Nyberg P, Nerbrand C, Ojehagen A, Samsioe G, Schersten B, Agardh C D. Biological factors are more important than socio-demographic and psychosocial conditions in relation to hypertension in middle-aged women. The Women's Health in the Lund Area (WHILA) study. Blood Press 2002; 11: 270–278
   PubMed Web of Science ®Google Scholar
• Li C, Wilawan K, Samsioe G, Lidfeldt J, Agardh C D, Nerbrand C. Health profile of middle-aged women: the Women's Health in the Lund Area (WHILA) study. Hum Reprod 2002; 17: 1379–1385
   PubMed Web of Science ®Google Scholar
• Lidfeldt J, Nerbrand C, Samsioe G. Women's Health in the Lund Area (WHILA) study. Climacteric medicine – Where do we go?, H PG Schneider, F Naftolin. Taylor and Francis, Abingdon 2005; 36–48
   Google Scholar
• Jernstrom H, Bendahl P O, Lidfeldt J, Nerbrand C, Agardh C D, Samsioe G. A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the Women's Health in the Lund Area (WHILA) study (Sweden). Cancer Causes Control 2003; 14: 673–680
   PubMed Web of Science ®Google Scholar
• Lidfeldt J, Nyberg P, Nerbrand C, Samsioe G, Schersten B, Agardh C D. Socio-demographic and psychological factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study. Diabetes Obes Metab 2003; 5: 106–112
   PubMed Web of Science ®Google Scholar
• Shakir Y, Samsioe G, Nyberg P, Lidfeldt J, Nerbrand C. Cardiovascular risk factors in middle-aged women and association with use of hormone therapy: results from a population-based study of the Swedish women. The Women's Health in the Lund Area (WHILA) Study. Climacteric 2004; 7: 274–283
   PubMed Web of Science ®Google Scholar
• Persson I, Yuen J, Bergkvist L, Schairer C. Cancer incidence and mortality in women receiving estrogen and estrogen–progestin replacement therapy – long-term follow-up of Swedish cohort. Int J Cancer 1996; 67: 327–332
   PubMed Web of Science ®Google Scholar
• Talamini R, Franceschi S, Dal Maso L, Negri E, Conti E, Filiberti R, Montella M, Nanni O, La Vecchia C. The influence of reproductive and hormonal factors on the risk of colon and rectal cancer in women. Eur J Cancer 1998; 34: 1070–1076
   Google Scholar
• Nichols H B, Trentham-Dietz A, Hampton J M, Newcomb P A. Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin. Cancer Epidemiol Biomarkers Prev 2005; 14: 1212–1218
   Google Scholar
• Chute C G, Willett W C, Colditz G A, Stampfer M J, Rosner B, Speizer F E. A prospective study of reproductive history and exogenous estrogen on the risk of colorectal cancer in women. Epidemiology 1991; 2: 201–207
   Google Scholar
• Ghatge R P, Jacobsen B M, Schittone S A, Horwitz K B. The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells. Breast Cancer Res 2005; 7: R1036–R1050
   PubMed Web of Science ®Google Scholar
• Schoonen W G, Deckers G H, De Gooijer M E, de Ries R, Kloosterboer H J. Hormonal properties of norethisterone, 7α-methyl-norethisterone and their derivatives. J Steroid Biochem Mol Biol 2000; 74: 213–222
   PubMed Web of Science ®Google Scholar
• Cagnacci A, De Toni A, Caretto S, Menozzi R, Bondi M, Corradini B, Alessandrini C, Volpe A. Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women. Menopause 2006; 13: 197–201
   PubMed Web of Science ®Google Scholar
• Grodstein F, Martinez M E, Platz E A, Giovannucci E, Colditz G A, Kautzky M, Fuchs C, Stampfer M J. Postmenopausal hormone use and the risk of colorectal adenoma and cancer. Ann Intern Med 1998; 128: 705–712
   PubMed Web of Science ®Google Scholar